The National Academies Press

Currently Skimming:

Appendix B Acronyms
Pages 217-220

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.

From page 217... ... Appendix B Acronyms ADR adverse drug report AE adverse event AER adverse event review AERS Adverse Event Reporting System AHRQ Agency for Healthcare Research and Quality BLA biologics license application CBER Center for Biologics Evaluation and Research CDC Centers for Disease Control and Prevention CDER Center for Drug Evaluation and Research CDRH Center for Devices and Radiological Health CERTS Center for Education and Research Therapeutics CFR Code of Federal Regulations CFSAN Center for Food Safety and Applied Nutrition CGMPs Current Good Manufacturing Practices CMS Centers for Medicare and Medicaid Services COPR Council of Public Representatives CVM Center for Veterinary Medicine DDMAC Division of Drug Marketing, Advertising and Communication DDRE Division of Drug Risk Evaluation DHHS Department of Health and Human Services DSaRM Drug Safety and Risk Management Advisory Committee Read the entire page →
From page 218... ... THE FUTURE OF DRUG SAFETY DSB Drug Safety Oversight Board DTCA direct-to-consumer advertising ELA established license application EMEA European Medicines Agency EU European Union FAA Federal Aviation Administration FDA Food and Drug Administration FDAMA Food and Drug Administration Modernization Act of 1997 FD&C Act Federal Food, Drug, and Cosmetic Act FOIA Freedom of Information Act FTC Federal Trade Commission FTE full-time equivalent FY fiscal year GAO Government Accountability Office GGP good guidance practice GLP good laboratory practice GMP good manufacturing practice GPRD General Practice Research Database GRMP good review manufacturing practice HIPAA Health Insurance Portability and Accountability Act IND Investigational New Drug IOM Institute of Medicine IRB institutional review board IT information technology MaPP Manual of Policies and Procedures MHRA Medicines and Healthcare Products Regulatory Agency NAS National Academy of Sciences NASA National Aeronautics and Space Administration NCTR National Center for Toxicological Research NDA New Drug Application NIH National Institutes of Health NME new molecular entity NSAID non-steroidal anti-inflammatory drug ODE Office of Drug Evaluation ODS Office of Drug Safety Read the entire page →
From page 219... ... APPENDIX B OIG Office of Inspector General OMB Office of Management and Budget OMP Office of Medical Policy OND Office of New Drugs OP Office of Planning OPaSS Office of Pharmacoepidemiology and Statistical Science OSE Office of Surveillance and Epidemiology PDUFA Prescription Drug User Fee Act PLA product license application RiskMAP risk minimization action plan SRS Spontaneous Reporting System UK United Kingdom USDA US Department of Agriculture VSD Vaccine Safety Datalink WHO World Health Organization Read the entire page →

From page 217...

... Appendix B Acronyms ADR adverse drug report AE adverse event AER adverse event review AERS Adverse Event Reporting System AHRQ Agency for Healthcare Research and Quality BLA biologics license application CBER Center for Biologics Evaluation and Research CDC Centers for Disease Control and Prevention CDER Center for Drug Evaluation and Research CDRH Center for Devices and Radiological Health CERTS Center for Education and Research Therapeutics CFR Code of Federal Regulations CFSAN Center for Food Safety and Applied Nutrition CGMPs Current Good Manufacturing Practices CMS Centers for Medicare and Medicaid Services COPR Council of Public Representatives CVM Center for Veterinary Medicine DDMAC Division of Drug Marketing, Advertising and Communication DDRE Division of Drug Risk Evaluation DHHS Department of Health and Human Services DSaRM Drug Safety and Risk Management Advisory Committee

Read the entire page →

From page 218...

... THE FUTURE OF DRUG SAFETY DSB Drug Safety Oversight Board DTCA direct-to-consumer advertising ELA established license application EMEA European Medicines Agency EU European Union FAA Federal Aviation Administration FDA Food and Drug Administration FDAMA Food and Drug Administration Modernization Act of 1997 FD&C Act Federal Food, Drug, and Cosmetic Act FOIA Freedom of Information Act FTC Federal Trade Commission FTE full-time equivalent FY fiscal year GAO Government Accountability Office GGP good guidance practice GLP good laboratory practice GMP good manufacturing practice GPRD General Practice Research Database GRMP good review manufacturing practice HIPAA Health Insurance Portability and Accountability Act IND Investigational New Drug IOM Institute of Medicine IRB institutional review board IT information technology MaPP Manual of Policies and Procedures MHRA Medicines and Healthcare Products Regulatory Agency NAS National Academy of Sciences NASA National Aeronautics and Space Administration NCTR National Center for Toxicological Research NDA New Drug Application NIH National Institutes of Health NME new molecular entity NSAID non-steroidal anti-inflammatory drug ODE Office of Drug Evaluation ODS Office of Drug Safety

Read the entire page →

From page 219...

... APPENDIX B OIG Office of Inspector General OMB Office of Management and Budget OMP Office of Medical Policy OND Office of New Drugs OP Office of Planning OPaSS Office of Pharmacoepidemiology and Statistical Science OSE Office of Surveillance and Epidemiology PDUFA Prescription Drug User Fee Act PLA product license application RiskMAP risk minimization action plan SRS Spontaneous Reporting System UK United Kingdom USDA US Department of Agriculture VSD Vaccine Safety Datalink WHO World Health Organization

Read the entire page →

Key Terms

← Previous Chapter Skim

Next Chapter Skim →

This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.

Appendix B Acronyms Pages 217-220

Appendix B Acronyms
Pages 217-220